Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 24, 1998 - Issue 3
Submit an article Journal homepage
73
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Flupenthixol Treatment for Cocaine Abusers with Schizophrenia: A Pilot Study

Frances Rudnick Levin Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York; College of Physicians and Surgeons of Columbia University, New York, New York
,
Suzette M. Evans Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York; College of Physicians and Surgeons of Columbia University, New York, New York
,
Siobhan Coomaraswammy Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York
,
Eric D. Collins Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York; College of Physicians and Surgeons of Columbia University, New York, New York
,
Nicole Regent Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York
&
Herbert D. Kleber Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, New York, New York; College of Physicians and Surgeons of Columbia University, New York, New York
Pages 343-360 | Published online: 07 Jul 2009

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Melanie E. Bennett, Kristen R. Bradshaw & Lauren T. Catalano. (2017) Treatment of substance use disorders in schizophrenia. The American Journal of Drug and Alcohol Abuse 43:4, pages 377-390.
Read now
Maju Mathew Koola, HeidiJ. Wehring & DeannaL. Kelly. (2012) The Potential Role of Long-Acting Injectable Antipsychotics in People With Schizophrenia and Comorbid Substance Use. Journal of Dual Diagnosis 8:1, pages 50-61.
Read now
Nesrin Dilbaz & Aslı Enez Darçın. (2011) Şizofreni ve Madde Kullanım Bozukluğu Eş Tanılı Hastalarda Tedavi. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 21:1, pages 80-90.
Read now
Élie Rizkallah, Emmanuel Stip, Simon Zhornitsky, Tania Pampoulova, Alain Gendron, Pierre-Paul Rompré, Jean-Pierre Chiasson & Stéphane Potvin. (2010) Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion on Pharmacotherapy 11:18, pages 2947-2951.
Read now
Thomas Wobrock & Michael Soyka. (2009) Pharmacotherapy of patients with schizophrenia and substance abuse. Expert Opinion on Pharmacotherapy 10:3, pages 353-367.
Read now
Evaristo Akerele & Frances R. Levin. (2007) Comparison of Olanzapine to Risperidone in Substance-Abusing Individuals with Schizophrenia. American Journal on Addictions 16:4, pages 260-268.
Read now
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller, WFSBP Task Force on Treatment Guidelines for Schizophrenia, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller & WFSBP Task Force on Treatment Guidelines for Schizophrenia. (2005) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia. The World Journal of Biological Psychiatry 6:3, pages 132-191.
Read now
Vanessa Crawford, Ilana B. Crome & Carmel Clancy. (2003) Co-existing Problems of Mental Health and Substance Misuse (Dual Diagnosis): a literature review. Drugs: Education, Prevention and Policy 10:1, pages 1-74.
Read now

Articles from other publishers (32)

Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo d'Andrea, Alessandra Napolitano, Monica Santangelo, Corradina Esposito, Anna Rosazza, Elena Haefele, Gilberto Di Petta, Mauro Pettorruso, Stefano L. Sensi & Giovanni Martinotti. (2023) Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study. Advances in Dual Diagnosis 16:3, pages 185-198.
Crossref
Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Valentin Skryabin, Stefano L. Sensi & Massimo Di Giannantonio. (2022) Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice. Current Pharmaceutical Design 28:27, pages 2241-2259.
Crossref
Alexandria S. Coles, Dunja Knezevic, Tony P. George, Christoph U. Correll, John M. Kane & David Castle. (2021) Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Kruti Joshi, Marie-Hélène Lafeuille, Rhiannon Kamstra, Sean Tiggelaar, Patrick Lefebvre, Edward Kim, Yong Yue & Neeta Tandon. (2018) Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits. Journal of Comparative Effectiveness Research 7:2, pages 121-133.
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Thomas M. Kelly, Dennis C. Daley & Antoine B. Douaihy. (2012) Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors 37:1, pages 11-24.
Crossref
Thomas Wobrock, Dirk Czesnik & Berend Malchow. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume III. Handbook of Schizophrenia Spectrum Disorders, Volume III 321 363 .
A Fasano & I Petrovic. (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Molecular Psychiatry 15:6, pages 560-573.
Crossref
T. Wobrock & M. Soyka. (2008) Pharmacotherapy of schizophrenia with comorbid substance use disorder — Reviewing the evidence and clinical recommendations. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:6, pages 1375-1385.
Crossref
T. Wobrock, R. D’Amelio & P. Falkai. (2007) Pharmakotherapie bei Schizophrenie und komorbider SubstanzstörungPharmacotherapy of schizophrenia and comorbid substance use disorder. Der Nervenarzt 79:1, pages 17-35.
Crossref
Alan I. Green. (2007) Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Neurotoxicity Research 11:1, pages 33-39.
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction 171 243 .
DOUGLAS M. ZIEDONIS, DAVID SMELSON, RICHARD N. ROSENTHAL, STEVEN L. BATKI, ALAN I. GREEN, RENATA J. HENRY, IVAN MONTOYA, JOSEPH PARKS & ROGER D. WEISS. (2005) Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations. Journal of Psychiatric Practice 11:5, pages 315-339.
Crossref
Thomas P. Beresford, Lori Clapp, Brandon Martin, John L. Wiberg, Julie Alfers & Henry F. Beresford. (2005) Aripiprazole in Schizophrenia With Cocaine Dependence. Journal of Clinical Psychopharmacology 25:4, pages 363-366.
Crossref
Robert M. Roth, Mary F. Brunette & Alan I. Green. (2005) Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?. Current Psychiatry Reports 7:4, pages 283-291.
Crossref
Steven L. Sayers, E Cabrina Campbell, Janienne Kondrich, Stephan C. Mann, James Cornish, Charles O'Brien & Stanley N. Caroff. (2005) Cocaine Abuse in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol. Journal of Nervous & Mental Disease 193:6, pages 379-386.
Crossref
Ilana B. Crome & Tracey Myton. (2018) Pharmacotherapy in dual diagnosis. Advances in Psychiatric Treatment 10:6, pages 413-424.
Crossref
Stéphane Potvin & Jean-Yves Roy. (2004) The Effect of Quetiapine on Cannabis Use in 8 Psychosis Patients with Drug Dependency. The Canadian Journal of Psychiatry 49:10, pages 711-711.
Crossref
A. R. Lingford-Hughes, S. Welch & D. J. Nutt. (2016) Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 18:3, pages 293-335.
Crossref
John Grabowski, James Shearer, John Merrill & S. Stevens Negus. (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 29:7, pages 1439-1464.
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse 139 199 .
Stéphane Potvin, Emmanuel Stip & Jean-Yves Roy. (2003) Clozapine, quetiapine and olanzapine among addicted schizophrenic patients. International Clinical Psychopharmacology 18:3, pages 121-132.
Crossref
St??phane Potvin, Emmanuel Stip & Jean-Yves Roy. (2003) Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. International Clinical Psychopharmacology 18:3, pages 121-132.
Crossref
David A Smelson, Miklos F Losonczy, Craig W Davis, Maureen Kaune, John Williams & Douglas Ziedonis. (2002) Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence. The Canadian Journal of Psychiatry 47:7, pages 671-675.
Crossref
EVARISTO O. AKERELE & FRANCES R. LEVIN. (2002) Substance Abuse Among Patients with Schizophrenia. Journal of Psychiatric Practice 8:2, pages 70-80.
Crossref
Jane Edwards, Mark Hinton, Kathryn Elkins & Olympia Athanasopoulos. 2002. Substance Misuse in Psychosis. Substance Misuse in Psychosis 283 304 .
Suzette M Evans, Sharon L Walsh, Frances R Levin, Richard W Foltin, Marian W Fischman & George E Bigelow. (2001) Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug and Alcohol Dependence 64:3, pages 271-283.
Crossref
Dharam Agarwal & Helmut SeitzMichael Soyka & Christian Schütz. 2001. Alcohol in Health and Disease. Alcohol in Health and Disease 207 224 .
Douglas M Ziedonis & Robert Stern. (2001) Dual Recovery Therapy for Schizophrenia and Substance Abuse. Psychiatric Annals 31:4, pages 255-264.
Crossref
Michael Soyka & Jean De Vry. (2000) Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence. European Neuropsychopharmacology 10:5, pages 325-332.
Crossref
Douglas Ziedonis, Jill Williams, Patrick Corrigan & David Smelson. (2000) Management of Substance Abuse in Schizophrenia. Psychiatric Annals 30:1, pages 67-75.
Crossref
F. R. Levin & H. D. Kleber. 2000. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid 547 577 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.